Bayer proposes $7.25 billion class action settlement in Roundup litigation
In a bold bid to put costly US Roundup litigation behind it, Bayer on Tuesday announced a $7.25 billion proposed class action settlement for users of its glyphosate-based weed killing products who have cancer now or develop cancer in the next several years, with average awards ranging from $10,000 to $165,000.